ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,534,267 | -24.6% | 1,099,154 | 0.0% | 0.11% | -24.3% |
| Q2 2023 | $39,195,831 | +50.5% | 1,099,154 | +7.2% | 0.14% | +44.0% |
| Q1 2023 | $26,051,611 | -37.4% | 1,025,654 | 0.0% | 0.10% | -34.2% |
| Q4 2022 | $41,600,526 | +13.9% | 1,025,654 | -7.2% | 0.15% | -1.9% |
| Q3 2022 | $36,539,000 | -6.2% | 1,105,587 | -0.1% | 0.16% | -1.3% |
| Q2 2022 | $38,965,000 | -24.9% | 1,106,662 | -1.9% | 0.16% | -7.6% |
| Q1 2022 | $51,879,000 | -30.6% | 1,128,062 | 0.0% | 0.17% | -30.9% |
| Q4 2021 | $74,790,000 | +6.0% | 1,128,062 | -0.2% | 0.25% | -5.4% |
| Q3 2021 | $70,568,000 | -24.8% | 1,130,363 | -0.3% | 0.26% | -24.2% |
| Q2 2021 | $93,881,000 | +24.9% | 1,133,563 | +0.0% | 0.34% | +5.9% |
| Q1 2021 | $75,145,000 | -21.7% | 1,133,246 | -9.4% | 0.32% | -29.4% |
| Q4 2020 | $95,940,000 | +41.2% | 1,250,369 | -20.8% | 0.46% | +31.1% |
| Q3 2020 | $67,969,000 | -0.3% | 1,578,473 | 0.0% | 0.35% | -11.2% |
| Q2 2020 | $68,174,000 | +46.6% | 1,578,473 | -2.3% | 0.39% | +30.9% |
| Q1 2020 | $46,492,000 | -64.6% | 1,616,023 | -21.9% | 0.30% | -54.3% |
| Q4 2019 | $131,174,000 | +54.0% | 2,068,020 | -31.6% | 0.66% | +40.3% |
| Q3 2019 | $85,169,000 | +4.4% | 3,022,325 | -1.9% | 0.47% | +3.5% |
| Q2 2019 | $81,615,000 | -9.7% | 3,079,825 | -37.4% | 0.45% | -13.2% |
| Q1 2019 | $90,346,000 | +44.7% | 4,923,525 | -2.1% | 0.52% | +34.2% |
| Q4 2018 | $62,436,000 | -35.6% | 5,027,125 | -0.5% | 0.39% | -24.6% |
| Q3 2018 | $96,883,000 | +57.2% | 5,053,925 | +11.6% | 0.52% | +45.4% |
| Q2 2018 | $61,611,000 | +88.6% | 4,530,250 | 0.0% | 0.36% | +90.9% |
| Q1 2018 | $32,663,000 | +179.0% | 4,530,250 | +42.4% | 0.19% | +190.6% |
| Q4 2017 | $11,707,000 | – | 3,181,350 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |